Evidence for replication of human endogenous retroviruses type-K (HERV-K) in HIV-1 positive patients by Contreras-Galindo, Rafael et al.
BioMed  Central
Page 1 of 1
(page number not for citation purposes)
Retrovirology
Open Access Oral presentation
Evidence for replication of human endogenous retroviruses type-K 
(HERV-K) in HIV-1 positive patients
Rafael Contreras-Galindo1,2, Angie Contreras-Galindo*, Eric Lorenzo3 and 
Yasuhiro Yamamura2
Address: 1Department of Internal Medicine, Division of Infectious Diseases, University of Michigan Medical Center, Ann Arbor, Michigan, 48109, 
USA, 2AIDS Research Program, Ponce School of Medicine, Ponce, Puerto Rico 00716-2348, USA and 3Department of Biochemistry, Ponce School 
of Medicine, Ponce, Puerto Rico 00716-2348, USA
Email: Rafael Contreras-Galindo - rafaelc@med.umich.edu
* Corresponding author    
Background
The infectious capacity of particle-coding human endog-
enous retrovirus type-K HERV-K(HML-2) virions is still
questionable.
Materials and methods
The full-length RNA env gene, necessary for cell-to-cell
transmission, was amplified from plasma samples (three
time-points) of six HIV-1 seropositive individuals and
sequenced in order to track the phylogenetic evolution of
HERV-K.
Results
Type-1 and Type-2 HERV-K(HML-2) were co-amplified.
Phylogenetic analyses revealed frequent detection of inter
and intra-subtype HERV-K(HML-2) recombinant env
sequences. Type-1 but not type-2 env sequences were
mostly edited at specific sites, originating a unique hyper-
mutated consensus sequence (K111), which cluster in a
unique phylogenetic branch. HERV-K sequences less than
98% similar to known proviruses suggest that these provi-
ruses are unfixed. dN/dS ratios < 1 strongly suggested that
HERV-K replicated by reinfection, which may explain the
finding of putative HERV-K recombinant and hypermu-
tated sequences.
Conclusion
Our data suggest that the HERV-K(HML-2) family code
for infectious viral particles. RNA recombination could
serve to efficiently remove mutated HERV-K alleles by
combining intact parts of different genomes
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